Silk-Fibroin-Based Strategies for Myocardial Infarction Repair: A Comprehensive Review
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27062885 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Shuyan Piao und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical Sciences, Jilin University, Changchun 130021, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Fibroins, Tissue Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Academic Enhancement Support Program of Hainan Medical University, specific research fund of the Innovation Platform for Academicians of Hainan Province.
Abstract (Originalsprache)
Myocardial infarction is a major cardiovascular event that leads to heart failure and death. Although current vascular regeneration and pharmacological therapies can salvage some myocardial tissue, they cannot effectively reverse established necrosis, fibrosis, or adverse ventricular remodeling, thus necessitating novel repair strategies. Silk fibroin (SF), a natural biomaterial, has emerged as an ideal substrate for cardiac tissue engineering owing to its excellent biocompatibility, tunable mechanical properties, and controllable biodegradability. This paper systematically reviews SF-based myocardial repair strategies: SF cardiac patches can be directly applied to infarct areas, providing mechanical support and delivering bioactive substances, while injectable SF hydrogels can be formed in situ via minimally invasive methods, serving as three-dimensional delivery vehicles for cells or drugs. These approaches synergistically promote cardiac repair through multiple mechanisms, including active regulation of inflammation, promotion of angiogenesis, and inhibition of fibrosis. Future development of SF-based therapies will focus on creating smart responsive materials, constructing biomimetic structures via advanced biomanufacturing techniques, and accelerating clinical translation, thereby providing comprehensive solutions for myocardial infarction repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
- Engineering Research Center of Tropical Medicine Innovation and Transformation of Ministry of Education & Hainan Provincial Key Laboratory of Research and Development on Tropical Herbs, School of Pharmacy, Hainan Medica…
Förderung
- National Natural Science Foundation of China
- Academic Enhancement Support Program of Hainan Medical University
- specific research fund of the Innovation Platform for Academicians of Hainan Province
- Innovation Platform for Academicians of Hainan Province
Zitieren
APA
Piao, S., & Gao, Y. (2026). Silk-Fibroin-Based Strategies for Myocardial Infarction Repair: A Comprehensive Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27062885
Vancouver
Piao S, Gao Y. Silk-Fibroin-Based Strategies for Myocardial Infarction Repair: A Comprehensive Review. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27062885
BibTeX
@article{Piao2026,
author = {Piao, Shuyan and Gao, Yanan},
title = {Silk-Fibroin-Based Strategies for Myocardial Infarction Repair: A Comprehensive Review},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27062885}
}
EUVIMED